上海昊海生物科技股份有限公司(股票代码：06826)于2026年10月26日公告称，当日通过香港联交所场内回购3.5万股H股，约占该公司当日现有已发行股份总数的0.0156%。此次回购每股价格介乎港币15.77元至16.00元，合计支付约55.89万港元。
根据公告，本次回购所涉股份尚未注销，因此公司已发行股本暂未发生变动。截至本次回购完成后，公司H股股本维持34,780,340股不变；其A股股本为190,203,760股，并持有3,848,095股A股为库藏股，合并计算后的普通股总数为224,984,100股。
公司于2026年5月29日取得股份回购授权，总规模为3,478,034股。本次回购完成后，公司已累计回购股份961,300股，占授权通过当日已发行股份总数的2.7639%。公告同时显示，公司已遵守上市规则及其他适用法律法规。
本公告由董事兼联席公司秘书田敏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.